Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.nejm.org › doi › fullEffect of Early Treatment with Ivermectin among Patients with...

   www.nejm.org › doi › full

   30 mar 2022 · The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the...

   • Original Article Two Phase 3 Trials of Baricitinib for Alopecia Areata B. King and Others

     We enrolled 654 patients in the BRAVE-AA1 trial and 546 in...

   • Images in Clinical Medicine Primary Cutaneous Blastomycosis A. Alhatem and K.C. Smith

     A 53-year-old landscaper presented with a 4-month history of...

   • Perspective Real-World Evidence — Where Are We Now J. Concato and J. Corrigan-Curay

     Interview with Kushal Kadakia on the 21st Century Cures Act,...

   • Clinical Practice Nonspecific Low Back Pain A. Chiarotto and B.W. Koes

     19. Traeger AC, Henschke N, Hübscher M, et al. Estimating...

   • Editorial Baricitinib in Alopecia Areata A. Messenger and M. Harries

     Convalescent Plasma for Covid-19 — Making Sense of the...

   • Clinical Problem-Solving Looking Back L. Glick and Others

     Treatment with allopurinol at a dose of 50 mg daily was...

   • Correspondence Dec 15, 2022 Ivermectin Treatment for Covid-19

     Given the wide availability and low cost of ivermectin and...

   • Editorial Audio Interview

     In this audio interview conducted on May 2, 2022, the...

2. www.sciencedirect.com › science › articleIvermectin for treatment of COVID-19: A systematic review and...

   www.sciencedirect.com › science › article

   30 mar 2024 · Despite no conclusive evidence or guidelines recommending ivermectin as a therapeutic drug for COVID-19, clinicians could use it with caution in the absence of better alternatives, and self-medication of ivermectin is not recommended for patients with COVID-19.

3. pubmed.ncbi.nlm.nih.gov › 33278625A five-day course of ivermectin for the treatment of COVID-19 may...

   pubmed.ncbi.nlm.nih.gov › 33278625

   A 5-day course of ivermectin was found to be safe and effective in treating adult patients with mild COVID-19. Larger trials will be needed to confirm these preliminary findings. Keywords: Bangladesh; COVID-19; Doxycycline; Ivermectin; SARS-CoV-2.

4. www.thelancet.com › journals › eclinmAntiviral effect of high-dose ivermectin in adults with COVID-19:...

   www.thelancet.com › journals › eclinm

   17 cze 2021 · A concentration dependent antiviral effect of ivermectin in COVID-19 was identified, with significant reductions in SARS-CoV-2 viral load in respiratory secretions among patients achieving high systemic ivermectin concentration compared to untreated controls.

5. journal.chestnet.org › article › S0012-3692(21)00476-1Standard Dose Ivermectin for COVID-19 - CHEST

   journal.chestnet.org › article › S0012-3692(21)00476-1

   12 paź 2020 · The article by Ceplowicz Rajter et al1 published in CHEST (January 2021), which presents a significant effect of ivermectin at standard dose on COVID-19 mortality rates, raises once again important questions on the significance of observational studies that report posttreatment outcome for COVID-19.

6. www.nejm.org › doi › fullIvermectin Treatment for Covid-19 | New England Journal of...

   www.nejm.org › doi › full

   14 gru 2022 · Given the wide availability and low cost of ivermectin and that the dosage used in the trial appeared to be safe, such treatment effects could be an important benefit for high-risk patients who do...

7. www.sciencedirect.com › science › articleEfficacy and safety of ivermectin for treatment of...

   www.sciencedirect.com › science › article

   1 sie 2024 · Efficacy of single-dose and double-dose ivermectin early treatment in preventing progression to hospitalization in mild COVID-19: a multi-arm, parallel-group randomized, double-blind, placebo-controlled trial